Cargando…
Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases
Treatments for ‘superbug’ infections are the focus for innovative research, as drug resistance threatens human health and medical practices globally. In particular, Acinetobacter baumannii (Ab) infections are repeatedly reported as difficult to treat due to increasing antibiotic resistance. Therefor...
Autores principales: | Cross, Emily M., Adams, Felise G., Waters, Jack K., Aragão, David, Eijkelkamp, Bart A., Forwood, Jade K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007833/ https://www.ncbi.nlm.nih.gov/pubmed/33782435 http://dx.doi.org/10.1038/s41598-021-86400-1 |
Ejemplares similares
-
The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance
por: Zang, Maoge, et al.
Publicado: (2021) -
Characterizing the role of phosphatidylglycerol-phosphate phosphatases in Acinetobacter baumannii cell envelope biogenesis and antibiotic resistance
por: Zang, Maoge, et al.
Publicado: (2022) -
3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds
por: Liu, Jian, et al.
Publicado: (2013) -
A novel 3‐oxoacyl‐ACP reductase (FabG3) is involved in the xanthomonadin biosynthesis of Xanthomonas campestris pv. campestris
por: Yu, Yonghong, et al.
Publicado: (2019) -
Structure-based identification of novel inhibitors targeting the enoyl-ACP reductase enzyme of Acinetobacter baumannii
por: Khan, Shama, et al.
Publicado: (2023)